The goal of Omnicare’s Clinical Services Podcast Series is to touch on relevant topics that are common to the Post-Acute Care setting. These educational videos are provided for informational and reference purposes only. They do not constitute medical, legal, or regulatory advice and are not a substitute for appropriate training and education and treatment by an appropriate medical provider.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Podcast by Future Science Group
…
continue reading
Liberty-minded news, witticisms, and general hot takes - for the folks who want their liberty on the go.
…
continue reading
The New FDA Approvals podcast is a weekly podcast that aims to help clinicians, medical writers, and pharmaceutical industry executives stay up to date on the latest FDA approvals. Join Dr. Emma Hitt Nichols each Monday morning for an update on the previous week’s FDA activities.
…
continue reading
1
The new frontier: assessing efficacy and safety of CGTs using biomarkers
24:21
24:21
Play later
Play later
Lists
Like
Liked
24:21
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of w…
…
continue reading
1
Managing Heart Failure in the Post Acute Setting
9:58
9:58
Play later
Play later
Lists
Like
Liked
9:58
The Center for Disease Control (or CDC) estimates that one third of residents in long term care has heart failure and approximately 1 in 4 persons will develop heart failure in their lifetime. Today, our discussion will cover how to recognize and signs and symptoms of heart failure and understanding the treatment options (and teaching opportunities…
…
continue reading
1
S1 Ep128: Advancing Glioblastoma Research Through a Phase 3 Niraparib Trial
20:23
20:23
Play later
Play later
Lists
Like
Liked
20:23
In a conversation with CancerNetwork®, Nader Sanai, MD discussed the current state of the glioblastoma field, highlighting ongoing research efforts to help improve outcomes among patients with this disease. Sanai is the director of the Ivy Brain Tumor Center and J.N Harber Professor of Neurological Surgery, Francis and Dionne Najafi chair for Neuro…
…
continue reading
1
S1 Ep127: Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs
7:34
7:34
Play later
Play later
Lists
Like
Liked
7:34
In a conversation with CancerNetwork®, Georgios Evangelou, MD, MSc spoke about his manuscript titled Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs, which he and his coauthors published in the July issue of ONCOLOGY®. Evangelou, a medical oncologist and consultant in the 3rd Department of Medicine at Sotiria General Hospital in At…
…
continue reading
Carlon Fitzpatrick AI Summit by Future Science GroupBy Future Science Group
…
continue reading
1
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation
18:53
18:53
Play later
Play later
Lists
Like
Liked
18:53
In a conversation with CancerNetwork®, Jessica Cheng, MD, spoke about her work in the growing field of physical medicine and rehabilitation (PMR) and how it may improve quality of life outcomes among patients with cancer. Above all else, Cheng, an assistant clinical professor in the Department of Supportive Care Medicine at City of Hope, emphasized…
…
continue reading
1
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
18:21
18:21
Play later
Play later
Lists
Like
Liked
18:21
In a special co-branded episode between Oncology On the Go and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Rahul Banerjee, MD, FACP, and Noopur Raje, MD, discussed the risk of secondary malignancies in patients with multiple myeloma who receive CAR T-cell therapy. Banerjee is an assistant professor i…
…
continue reading
1
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
11:56
11:56
Play later
Play later
Lists
Like
Liked
11:56
In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patie…
…
continue reading
1
Annual Influenza Vaccine: Administration, Storage, and Handling
10:10
10:10
Play later
Play later
Lists
Like
Liked
10:10
Omnicare nurse experts we will be discussing the safe administration, storage, and handling of Flu vaccines. According to the Centers for Disease Control and Prevention (CDC), an annual influenza vaccine is the "best protection" to reduce the risk of influenza and its potentially serious complications. This information is intended to help provide i…
…
continue reading
1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
10:56
10:56
Play later
Play later
Lists
Like
Liked
10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…
…
continue reading
1
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-…
…
continue reading
1
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
28:08
28:08
Play later
Play later
Lists
Like
Liked
28:08
CancerNetwork® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of…
…
continue reading
1
Challenges and solutions in monitoring assay performance for vaccine development
18:26
18:26
Play later
Play later
Lists
Like
Liked
18:26
Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul ChaudhariBy Future Science Group
…
continue reading
1
Leqselvi for Alopecia Areata, Femlyv Dissolvable Birth Control, Brineura for Batten Disease, Erzofri for Schizophrenia, Eque-cel for MS, Spravato for TRD, ZW191 Anti-Tumor Agent
9:46
9:46
Play later
Play later
Lists
Like
Liked
9:46
Use AI to Speed up Your Work Flow Ethically and Securely. There are lots of courses on AI out there, but this one is specific only to medical writing and editing. Access the AIMWE course waitlist. https://www.learnamastyle.com/waitlist/ Leqselvi for Alopecia Areata: The FDA has approved deuruxolitinib (Leqselvi) as a first-line treatment for adults…
…
continue reading
1
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
15:37
15:37
Play later
Play later
Lists
Like
Liked
15:37
In a conversation with CancerNetwork®, Nausheen Ahmed, MD, spoke about optimizing monitoring strategies for patients with B-cell non-Hodgkin lymphoma who undergo treatment with CAR T-cell therapy. Ahmed, an associate professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, discussed…
…
continue reading
For today’s topic, we will be discussing depression as it relates to our older population, recognizing signs and symptoms, and nursing assessment & interventions to ensure patient safety and improve patient care.By CVS Omnicare
…
continue reading
1
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow …
…
continue reading
1
Voquenza for GERD, ADI-270 for Clear Cell Renal Cell Carcinoma, Lomecel-B in AD, ART26.12 for Chemotherapy-Induced Peripheral Neuropathy, Test for Candida auris, Botensilimab/balstilimab in mCRC
10:20
10:20
Play later
Play later
Lists
Like
Liked
10:20
Visit learnAMAstyle.com to uplevel your writing and editing skills with free downloads on medical writing and editing. The FDA has approved vonoprazan (Voquenza) for treating non-erosive gastroesophageal reflux disease (GERD) in adults. Vonoprazan is an oral potassium-competitive acid blocker (PCAB) already approved for erosive esophagitis and Heli…
…
continue reading
1
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
19:14
19:14
Play later
Play later
Lists
Like
Liked
19:14
As part of the Breaking Barriers: Women in Oncology program, CancerNetwork® spoke with Julie M. Vose, MD, MBA, and Avyakta Kallam, MD, about the evolution of their careers in the hematology-oncology space, including some of the critical advances and challenges associated with their work in the lymphoma field. Vose is division chief, Neumann M. and …
…
continue reading
1
Blincyto for B-ALL, Zorvye for Atopic Dermatitis, Vabysmo Pre-filled Syringe, OX124 for Opioid Overdose Reversal, Voquezna for GERD
9:59
9:59
Play later
Play later
Lists
Like
Liked
9:59
Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences. The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-c…
…
continue reading
1
ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff
11:13
11:13
Play later
Play later
Lists
Like
Liked
11:13
We caught up with Principal Scientist Lindsay Denhoff (ICON; Dublin, Ireland) to discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs). Lindsay shares some industry best practices for achieving high-quality ADA assays, as well as some of t…
…
continue reading
1
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
13:01
13:01
Play later
Play later
Lists
Like
Liked
13:01
Tycel Phillips, MD, spoke with CancerNetwork® ahead of the FDA’s accelerated approval of epcoritamab-bysp (Epkinly) for patients with relapsed/refractory follicular lymphoma to discuss how this agent may impact the treatment paradigm. Phillips, an associate professor in the Division of Lymphoma and Department of Hematology & Hematopoietic Stem Cell…
…
continue reading
1
Kisunla for Alzheimer’s, Sirturo for TB, Kar-XT for Schizophrenia, MDMA-based Therapy for PTSD, Seladelpar for PBC, TransCon PTH for Hypoparathyroidism, Afami-Cel for Synovial Sarcoma
11:10
11:10
Play later
Play later
Lists
Like
Liked
11:10
Visit learnamastyle.com for free downloads and free courses related to writing in medicine and science. - The FDA has approved donanemab (Kisunla) for early symptomatic Alzheimer's disease, making it the third drug in a new class aimed at slowing cognitive decline in early-stage patients. Eli Lilly will make the drug available within weeks followin…
…
continue reading
1
Ohtuvayre for COPD, Tepylute for Breast and Ovarian Cancer, Epkinly for R/R FL, Sofdra for Primary Axillary Hyperhidrosis, Wakix for Narcolepsy, PiaSky for PNH, Efgartigimod for CIDP, IBI343 for Pancreatic ...
12:54
12:54
Play later
Play later
Lists
Like
Liked
12:54
Do you work for a CME company that needs urgent medical writing assistance? We can help. Visit nascentmc.com - The FDA has approved ensifentrine (Ohtuvayre) as an inhaled maintenance therapy for adults with COPD. Ohtuvayre is the first new mechanism of action for COPD treatment in over two decades, offering anti-inflammatory and bronchodilatory eff…
…
continue reading
1
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
31:49
31:49
Play later
Play later
Lists
Like
Liked
31:49
In a conversation with CancerNetwork®, James B. Yu, MD, MHS, FASTRO, and Julian C. Hong, MD, MS, spoke about their study titled AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care, which was published in the May issue of the journal ONCOLOGY®. Yu is a radiation oncologist in the Department of Radiation Oncology at Smilo…
…
continue reading
1
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024
8:13
8:13
Play later
Play later
Lists
Like
Liked
8:13
At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting. Manali Kamdar, MD, an associate professor of medicine-hematology and clinic…
…
continue reading
1
Capvaxive Pneumococcal Conjugate Vaccine, Elevidys for DMD, Krazati for CRC, Keytruda for Endometrial Cancer, Skyrizi for UC, Tremfya for Crohn’s Disease
10:08
10:08
Play later
Play later
Lists
Like
Liked
10:08
Visit nascentmc.com for the full writup of this episode and medical writing assistance. Visit learnamastyle.com for free downloads directed towards medical writing and editing. • The FDA has approved the 21-valent pneumococcal conjugate vaccine, CAPVAXIVE™ (Merck), for the prevention of invasive disease and pneumonia in adults aged 18 years and old…
…
continue reading
1
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice
31:19
31:19
Play later
Play later
Lists
Like
Liked
31:19
Following the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field. Iyengar is an associate attending physician at Memorial Sloan Kettering Cancer…
…
continue reading
1
Adbry for Atopic Dermatitis, Augtyro for NTRK Tumors, Donanemab for Alzheimer's, Iqirvo for Primary Biliary Cholangitis, Retevmo in Thyroid Cancer, OTC Continuous Glucose Monitors
8:38
8:38
Play later
Play later
Lists
Like
Liked
8:38
Check out Nascentmc.com for medical writing assistance. visit learnAMAstyle.com for free downloads on medical writing and editing Adbry for Atopic Dermatitis The FDA has approved tralokinumab-ldrm (Adbry) as a 300 mg single-dose autoinjector for moderate-to-severe atopic dermatitis (AD) in adults, offering a more convenient delivery method. Adbry, …
…
continue reading
1
Klisyri for Actinic Keratosis, MDMA for PTSD, Arexvy for RSV, Rytelo for MDS, Firdapse for LEMS
10:05
10:05
Play later
Play later
Lists
Like
Liked
10:05
Nascentmc.com for medical writing assistance for your company. Visit learnAMAstyle.com for free downloads on medical writing and editing Klisyri for Actinic Keratosis: The FDA has approved tirbanibulin (Klisyri) for treating actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm². Previously approved for areas up to 25 cm² in Dec…
…
continue reading
1
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval
13:43
13:43
Play later
Play later
Lists
Like
Liked
13:43
In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). T…
…
continue reading
1
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
26:47
26:47
Play later
Play later
Lists
Like
Liked
26:47
In a conversation with CancerNetwork®, Terence T. Sio, MD, MS, discussed how technological advancements in radiation oncology have impacted the modern treatment landscape for patients with non–small cell lung cancer (NSCLC). Sio, a professor of radiation oncology at Mayo Clinic in Phoenix, Arizona, first outlined the use of immunotherapy and other …
…
continue reading
1
mRESVIA for Lower Respiratory Tract Disease, Breyanzi for R/R MCL, Sarclisa for ND MM, Onyda XR for ADHD, Bkemv for PNH and aHUS, Austedo in Huntington’s
9:29
9:29
Play later
Play later
Lists
Like
Liked
9:29
Go here for complete show notes. Visit learnAMAstyle.com for free downloads on medical writing and editing Nascentmc.com for medical writing assistance for your company. mRESVIA for Lower Respiratory Tract Disease The FDA approved mRNA-1345 (mRESVIA) for preventing RSV-caused lower respiratory tract disease in adults 60 and older, based on Phase 3 …
…
continue reading
1
S1 Ep111: Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions
21:37
21:37
Play later
Play later
Lists
Like
Liked
21:37
Through elaborate multidisciplinary collaboration, institutions with National Accreditation Program for Rectal Cancer (NAPRC) standards can deliver a “high level of care” in the surgical treatment of patients with rectal cancer, according to Steven Wexner, MD, PhD, and Arielle Kanters, MD. In a conversation with CancerNetwork®, Wexner and Kanters d…
…
continue reading
For today’s topic, we will be discussing psychotropic medications as they relate to nursing considerations for behavior monitoring, side effect tracking, and care planning for the care of your residents taking psychotropic medications.By CVS Omnicare
…
continue reading
1
Imdelltra for EC-SCLC, Breyanzi for R/R LL, SNB-101 for SCLC, Upstaza for AADC Deficiency, Altuviiio for Hemophilia A Label Update, Self-Collected Sample for Cervical Cancer Screening, Clinolipid Parenteral ...
10:01
10:01
Play later
Play later
Lists
Like
Liked
10:01
For medical writing assistance, please visit nascentmc.com learnAMAstyle.com for the AI in Medical Writing and Editing: Blueprint for Success in a Changing World course to assist with implementing AI in medical writing. • Imdelltra for EC-SCLC: The FDA granted accelerated approval for tarlatamab-dlle (Imdelltra) for adults with extensive-stage smal…
…
continue reading
1
S1 Ep110: Finding a Place for Exercise Oncology in the Treatment of Breast Cancer
25:11
25:11
Play later
Play later
Lists
Like
Liked
25:11
In a conversation with CancerNetwork® at Memorial Sloan Kettering Cancer Center (MSKCC), Neil M. Iyengar, MD, spoke about developments and challenges in his career as a medical oncologist and clinical investigator as well as ongoing research efforts in improving outcomes among patients with breast cancer. Iyengar, a breast oncologist in in the Depa…
…
continue reading
In this Tech Blast episode supported by Sartorius (Göttingen, Germany), we speak with David Apiyo – Manager of Applications Development at Sartorius (MN, USA) – about epitope binning, why it's performed and the best ways to conduct it. Plus, learn more about Sartorius' biolayer interferometry platforms and their application in epitope binning.…
…
continue reading
1
mRNA Anti-EBV Cancer Vaccine, BTX-9341 for Breast Cancer, Nivolumab Hyaluronidase Formulation, ColoSense Colorectal Cancer Screening Test
6:40
6:40
Play later
Play later
Lists
Like
Liked
6:40
Visit NascentMC.com for medical writing assistance. Visit learnAMAstyle.com for information on AI in Medical Writing and Editing - **mRNA Anti-EBV Cancer Vaccine**: The novel mRNA therapeutic cancer vaccine WGc-043 has been approved for clinical trials by the FDA, targeting Epstein-Barr virus (EBV) related cancers such as nasopharyngeal carcinoma a…
…
continue reading
1
S1 Ep109: Leveraging Surgical Oncology Advances in Colorectal Cancer Care
6:13
6:13
Play later
Play later
Lists
Like
Liked
6:13
In a discussion with CancerNetwork® at John Theurer Cancer Center, Gregory Charak, MD, highlighted advancements in surgical treatment strategies for patients with colorectal cancer (CRC) as well as other ongoing challenges in the field. Specifically, Charak, a board-certified colorectal surgeon at Palisades Medical Center and Hackensack University …
…
continue reading
1
Ingrezza Sprinkles for Huntington’s, Tivdak for Cervical Cancer, Xolremdi for WHIM, Esprit Stent for CLTI-BTK
6:55
6:55
Play later
Play later
Lists
Like
Liked
6:55
Please visit Nascentmc.com for medical writing assistance for your company. Visit learnAMAstyle.com for free downloads on medical writing and editing Ingrezza for Huntington’s: The FDA has approved valbenazine (INGREZZA® SPRINKLE) capsules for adults with tardive dyskinesia and chorea associated with Huntington's disease. This new oral granules for…
…
continue reading
1
S1 Ep108: Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
8:55
8:55
Play later
Play later
Lists
Like
Liked
8:55
During the 2024 Oncology Nursing Society Congress, CancerNetwork® spoke with multiple registered nurses about research they presented on safely administering treatment options such as CAR T-cell therapy and bispecific T-cell engager (BiTE) therapy in patients with multiple myeloma and other malignancies. Ishmael Applewhite, BSN, RN-BC, OCN, a regis…
…
continue reading
1
Using the Gyrolab® platform for oligo quantification: an interview with John Chappell
6:35
6:35
Play later
Play later
Lists
Like
Liked
6:35
In this interview, we spoke to John Chappell, Senior Global Scientific Support Manager at Gyros Protein Technologies (Uppsala, Sweden) about his experience working with the Gyrolab platform for oligonucleotide assays. John discusses the advantages of using Gyrolab for oligo quantification in biological fluids and shares his thoughts on the next ste…
…
continue reading
1
Beqvez for Hemophilia B, Anktiva for Bladder Cancer, Pivya for UTI, Tovorafenib for Pediatric Low-Grade Glioma, Entyvio Maintenance for Crohn’s Disease, Alecensa for NSCLC, SPG601 for Fragile X Syndrome ...
11:35
11:35
Play later
Play later
Lists
Like
Liked
11:35
VIsit Nascentmc.com for medical writing assistance. Visit learnamastyle.com for freebies on medical writing and editing and ChatGPT. - Fasenra Pediatric Asthma Expansion: No details provided for this update. - Beqvez for Hemophilia B: FDA approved gene therapy, Beqvez, for adults with moderate to severe hemophilia B, which enables the production of…
…
continue reading
1
S1 Ep107: Applying Novel Radiotherapy Technology for Brain Tumors and Other Cancers
17:51
17:51
Play later
Play later
Lists
Like
Liked
17:51
In a conversation with CancerNetwork® at John Theurer Cancer Center, Timothy Chen, MD, highlighted various novel treatment strategies that have impacted his care of patients with brain tumors and other types of cancer. Chen, a board-certified radiation oncologist and medical director of the Central Nervous System Program at Jersey Shore University …
…
continue reading
1
The new frontier: qPCR vs ddPCR for cell and gene therapies
15:41
15:41
Play later
Play later
Lists
Like
Liked
15:41
In the fifth episode of The New Frontier podcast, we're joined by Paul Byrne, Senior Director of Genomics from ProtaGene (MA, USA). Paul describes his experience working with qPCR vs digital and digital droplet PCR assays and advises on their pros and cons, as well as when it's best to use each. We discuss how these assays can be optimized for cell…
…
continue reading
1
S1 Ep106: Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery
20:24
20:24
Play later
Play later
Lists
Like
Liked
20:24
The robotic-assisted biopsy platform Ion is a “game-changer” for patients with lung cancer, as it provides a quicker, less invasive surgical method for conducting a lung biopsy, according to Richard Lazzaro, MD. In a conversation with CancerNetwork, Lazzaro, the chief of Thoracic Surgery at the Southern Region of RWJBarnabas Health, spoke about his…
…
continue reading
For today’s topic, we will be discussing chronic kidney disease and nursing considerations for the care of residents with this diagnosis.By CVS Omnicare
…
continue reading
1
S1 Ep105: Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care
20:24
20:24
Play later
Play later
Lists
Like
Liked
20:24
During the 2024 Society of Surgical Oncology Annual Meeting (SSO), CancerNetwork® spoke with a variety of surgical oncology experts regarding the topline data they presented. Each conversation also expanded upon how these results can be implemented into the clinical space and the next research steps. First, Adrienne Bruce Shannon, MD, a complex gen…
…
continue reading
1
Fasenra Pediatric Asthma Expansion, Xcopri New Delivery Methods, New MRD Endpoint for Myeloma, Mpox PCR Test Home Collection Kit, Dovato for Adolescents With HIV
8:19
8:19
Play later
Play later
Lists
Like
Liked
8:19
Visit nascentmc.com/podcast for full show notes. - The FDA has expanded the approval of benralizumab (Fasenra) to include children aged 6 to 11 with severe eosinophilic asthma, building on its previous approval for patients aged 12 and older. Benralizumab is a monoclonal antibody that targets and reduces eosinophilic inflammation, crucial in the se…
…
continue reading